ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry Q9UM73


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name ALK_HUMAN
Primary accession number Q9UM73
Secondary accession numbers Q4ZFX9 Q53QQ6 Q53RZ4 Q59FI3 Q9Y4K6
Integrated into Swiss-Prot on March 27, 2002
Sequence was last modified on March 6, 2007 (Sequence version 2)
Annotations were last modified on    June 16, 2009 (Entry version 93)
Name and origin of the protein
Protein name ALK tyrosine kinase receptor [Precursor]
Synonyms EC 2.7.10.1
Anaplastic lymphoma kinase
CD246 antigen
Gene name
Name: ALK
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND GLYCOSYLATION.
DOI=10.1038/sj.onc.1201062; PubMed=9174053 [NCBI, ExPASy, EBI, Israel, Japan]
Morris S.W., Naeve C.W., Mathew P., James P.L., Kirstein M.N., Cui X., Witte D.P.;
"ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK).";
Oncogene 14:2175-2188(1997).
[2]
ERRATUM.
Morris S.W., Naeve C.W., Mathew P., James P.L., Kirstein M.N., Cui X., Witte D.P.;
Oncogene 15:2883-2883(1997).
[3]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ARG-1491 AND GLU-1529.
DOI=10.1038/sj.onc.1200849; PubMed=9053841 [NCBI, ExPASy, EBI, Israel, Japan]
Iwahara T., Fujimoto J., Wen D., Cupples R., Bucay N., Arakawa T., Mori S., Ratzkin B., Yamamoto T.;
"Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system.";
Oncogene 14:439-449(1997).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-1491 AND GLU-1529.
TISSUE=Brain;
Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F.;
Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ILE-1461.
DOI=10.1038/nature03466; PubMed=15815621 [NCBI, ExPASy, EBI, Israel, Japan]
Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., Wilson R.K.;
"Generation and annotation of the DNA sequences of human chromosomes 2 and 4.";
Nature 434:724-731(2005).
[6]
PARTIAL NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH NPM1.
DOI=10.1126/science.8122112; PubMed=8122112 [NCBI, ExPASy, EBI, Israel, Japan]
Morris S.W., Kirstein M.N., Valentine M.B., Dittmer K.G., Shapiro D.N., Saltman D.L., Look A.T.;
"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.";
Science 263:1281-1284(1994).
[7]
FUNCTION AS AN ONCOGENE.
PubMed=11387242 [NCBI, ExPASy, EBI, Israel, Japan]
Simonitsch I., Polgar D., Hajek M., Duchek P., Skrzypek B., Fassl S., Lamprecht A., Schmidt G., Krupitza G., Cerni C.;
"The cytoplasmic truncated receptor tyrosine kinase ALK homodimer immortalizes and cooperates with ras in cellular transformation.";
FASEB J. 15:1416-1418(2001).
[8]
CHROMOSOMAL TRANSLOCATION WITH ALO17 AND CARS.
DOI=10.1002/gcc.10033; PubMed=12112524 [NCBI, ExPASy, EBI, Israel, Japan]
Cools J., Wlodarska I., Somers R., Mentens N., Pedeutour F., Maes B., De Wolf-Peeters C., Pauwels P., Hagemeijer A., Marynen P.;
"Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.";
Genes Chromosomes Cancer 34:354-362(2002).
[9]
SUBSTRATE SPECIFICITY.
DOI=10.1021/bi0472954; PubMed=15938644 [NCBI, ExPASy, EBI, Israel, Japan]
Donella-Deana A., Marin O., Cesaro L., Gunby R.H., Ferrarese A., Coluccia A.M., Tartari C.J., Mologni L., Scapozza L., Gambacorti-Passerini C., Pinna L.A.;
"Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity.";
Biochemistry 44:8533-8542(2005).
[10]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1078; TYR-1092; TYR-1096; TYR-1131; TYR-1278; TYR-1282; TYR-1507; TYR-1584 AND TYR-1604, AND MASS SPECTROMETRY.
DOI=10.1038/nbt1046; PubMed=15592455 [NCBI, ExPASy, EBI, Israel, Japan]
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J.;
"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
Nat. Biotechnol. 23:94-101(2005).
[11]
CHROMOSOMAL TRANSLOCATION WITH SEC31A.
DOI=10.1002/ijc.21490; PubMed=16161041 [NCBI, ExPASy, EBI, Israel, Japan]
Panagopoulos I., Nilsson T., Domanski H.A., Isaksson M., Lindblom P., Mertens F., Mandahl N.;
"Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.";
Int. J. Cancer 118:1181-1186(2006).
[12]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1073/pnas.0507066103; PubMed=16565220 [NCBI, ExPASy, EBI, Israel, Japan]
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
"Phosphoproteome analysis of the human mitotic spindle.";
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
[13]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1078; TYR-1096; TYR-1278; TYR-1282; TYR-1283; TYR-1359 AND TYR-1507, AND MASS SPECTROMETRY.
DOI=10.1016/j.cell.2007.11.025; PubMed=18083107 [NCBI, ExPASy, EBI, Israel, Japan]
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.";
Cell 131:1190-1203(2007).
[14]
STRUCTURE BY NMR OF 1571-1589.
RIKEN structural genomics initiative (RSGI);
"Solution structure of the complex of the PTB domain of SNT-2 and 19-residue peptide (aa 1571-1589) of HALK.";
Submitted (APR-2008) to the PDB data bank.
[15]
VARIANTS [LARGE SCALE ANALYSIS] LEU-90; LEU-163; GLN-296; ALA-476; PHE-560; ILE-680; THR-704; SER-877; MET-1012; ASP-1121; THR-1274; LEU-1328; ASN-1416; LYS-1419; ARG-1429; ARG-1491 AND GLU-1529.
DOI=10.1038/nature05610; PubMed=17344846 [NCBI, ExPASy, EBI, Israel, Japan]
Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
"Patterns of somatic mutation in human cancer genomes.";
Nature 446:153-158(2007).
Comments
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
U62540; AAB71619.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U66559; AAC51104.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AB209477; BAD92714.1; ALT_INIT; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AC106870; AAX93126.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AC093756; AAX88892.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AC074096; AAY15027.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
IPI IPI00395632; -.
RefSeq NP_004295.2; -.
UniGene Hs.654469
3D structure databases
PDB
2YS5; NMR; -; B=1571-1589.[ExPASy / RCSB / EBI]
2YT2; NMR; -; A=1571-1589.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 2YS5; -.
2YT2; -.
ModBase Q9UM73.
Protein-protein interaction databases
IntAct Q9UM73; 61.
PTM databases
PhosphoSite Q9UM73; -.
Enzyme and pathway databases
BRENDA 2.7.10.1; 247.
Organism-specific databases
GeneCards GC02M029327; -.
H-InvDB HIX0024259; -.
HIX0030037; -.
HGNC HGNC:427; ALK.
GenAtlas ALK.
HPA HPA010694; -.
MIM 105590; gene. [NCBI / EBI]
Orphanet 98841; Anaplastic large cell lymphoma.
635; Neuroblastoma.
PharmGKB PA24719; -.
Gene expression databases
ArrayExpress Q9UM73; -.
Bgee Q9UM73; -.
CleanEx HS_ALK; -.
GermOnline ENSG00000171094; Homo sapiens.
Ontologies
GO
GO:0005887; Cellular component: integral to plasma membrane (traceable author statement from ProtInc).
GO:0005524; Molecular function: ATP binding (inferred from electronic annotation from UniProtKB-KW).
GO:0005515; Molecular function: protein binding (inferred from physical interaction from IntAct).
GO:0004716; Molecular function: receptor signaling protein tyrosine kinase activity (traceable author statement from ProtInc).
GO:0004714; Molecular function: transmembrane receptor protein tyrosine kinase activity (inferred from direct assay from UniProtKB).
GO:0007420; Biological process: brain development (traceable author statement from ProtInc).
GO:0006487; Biological process: protein amino acid N-linked glycosylation (inferred from mutant phenotype from UniProtKB).
GO:0006468; Biological process: protein amino acid phosphorylation (inferred from electronic annotation from InterPro).
GO:0007169; Biological process: transmembrane receptor protein tyrosine kinase signaling pathway (inferred from electronic annotation from InterPro).
QuickGo view.
Family and domain databases
InterPro IPR002172; LDL_rcpt_classA_cys-rich.
IPR000998; MAM.
IPR000719; Prot_kinase_core.
IPR017441; Protein_kinase_ATP_BS.
IPR002011; Recept_tyr_kinase-II_CS.
IPR001245; Tyr_pkinase.
IPR008266; Tyr_pkinase_AS.
Graphical view of domain structure.
Pfam PF00629; MAM; 1.
PF07714; Pkinase_Tyr; 1.
Pfam graphical view of domain structure.
PRINTS PR00109; TYRKINASE.
ProDom PD000001; Prot_kinase; 1.
[Domain structure / List of seq. sharing at least 1 domain]
SMART SM00192; LDLa; 1.
SM00219; TyrKc; 1.
SMART graphical view of domain structure.
PROSITE PS01209; LDLRA_1; FALSE_NEG.
PS50068; LDLRA_2; FALSE_NEG.
PS00740; MAM_1; FALSE_NEG.
PS50060; MAM_2; 2.
PS00107; PROTEIN_KINASE_ATP; 1.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00109; PROTEIN_KINASE_TYR; 1.
PS00239; RECEPTOR_TYR_KIN_II; 1.
PROSITE graphical view of domain structure (profiles).
Proteomic databases
PRIDE Q9UM73; -.
Genome annotation databases
Ensembl ENSG00000171094; Homo sapiens. [Contig view]
GeneID 238; -.
KEGG hsa:238; -.
Phylogenomic databases
HOGENOM Q9UM73; -.
HOVERGEN Q9UM73; -.
Other
DrugBank DB00171; Adenosine triphosphate.
NextBio 948; -.
SOURCE ALK; Homo sapiens.
ProtoNet Q9UM73.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; ATP-binding; Chromosomal rearrangement; Glycoprotein; Kinase; Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism; Proto-oncogene; Receptor; Repeat; Signal; Transferase; Transmembrane; Tyrosine-protein kinase.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
SIGNAL   1     18  18     Potential. 
CHAIN   19   1620  1602     ALK tyrosine kinase receptor. PRO_0000016740
TOPO_DOM   19   1038  1020     Extracellular (Potential). 
TRANSMEM   1039   1059  21     Potential. 
TOPO_DOM   1060   1620  561     Cytoplasmic (Potential). 
DOMAIN   264    427  164     MAM 1. 
DOMAIN   437    473  37     LDL-receptor class A. 
DOMAIN   478    636  159     MAM 2. 
DOMAIN   1116   1392  277     Protein kinase. 
NP_BIND   1122   1130  9     ATP (By similarity). 
COMPBIAS   816    940  125     Gly-rich. 
ACT_SITE   1249   1249        Proton acceptor (By similarity). 
BINDING   1150   1150        ATP (By similarity). 
MOD_RES   211    211        Phosphoserine. 
MOD_RES   1078   1078        Phosphotyrosine. 
MOD_RES   1092   1092        Phosphotyrosine. 
MOD_RES   1096   1096        Phosphotyrosine. 
MOD_RES   1131   1131        Phosphotyrosine. 
MOD_RES   1278   1278        Phosphotyrosine. 
MOD_RES   1282   1282        Phosphotyrosine; by autocatalysis. 
MOD_RES   1283   1283        Phosphotyrosine. 
MOD_RES   1359   1359        Phosphotyrosine. 
MOD_RES   1507   1507        Phosphotyrosine. 
MOD_RES   1584   1584        Phosphotyrosine. 
MOD_RES   1604   1604        Phosphotyrosine. 
CARBOHYD   169    169        N-linked (GlcNAc...) (Potential). 
CARBOHYD   244    244        N-linked (GlcNAc...) (Potential). 
CARBOHYD   285    285        N-linked (GlcNAc...) (Potential). 
CARBOHYD   324    324        N-linked (GlcNAc...) (Potential). 
CARBOHYD   411    411        N-linked (GlcNAc...) (Potential). 
CARBOHYD   424    424        N-linked (GlcNAc...) (Potential). 
CARBOHYD   445    445        N-linked (GlcNAc...) (Potential). 
CARBOHYD   563    563        N-linked (GlcNAc...) (Potential). 
CARBOHYD   571    571        N-linked (GlcNAc...) (Potential). 
CARBOHYD   627    627        N-linked (GlcNAc...) (Potential). 
CARBOHYD   709    709        N-linked (GlcNAc...) (Potential). 
CARBOHYD   808    808        N-linked (GlcNAc...) (Potential). 
CARBOHYD   863    863        N-linked (GlcNAc...) (Potential). 
CARBOHYD   864    864        N-linked (GlcNAc...) (Potential). 
CARBOHYD   886    886        N-linked (GlcNAc...) (Potential). 
CARBOHYD   986    986        N-linked (GlcNAc...) (Potential). 
VARIANT   90     90  1     S -> L. VAR_041477 
VARIANT   163    163  1     V -> L. VAR_041478 
VARIANT   296    296  1     E -> Q. VAR_041479 
VARIANT   476    476  1     V -> A. VAR_041480 
VARIANT   560    560  1     L -> F (in a breast pleomorphic lobular carcinoma sample; somatic mutation). VAR_041481 
VARIANT   680    680  1     T -> I. VAR_041482 
VARIANT   704    704  1     A -> T. VAR_041483 
VARIANT   877    877  1     A -> S (in an ovarian serous carcinoma sample; somatic mutation). VAR_041484 
VARIANT   1012   1012  1     T -> M. VAR_041485 
VARIANT   1121   1121  1     G -> D. VAR_041486 
VARIANT   1274   1274  1     A -> T. VAR_041487 
VARIANT   1328   1328  1     M -> L. VAR_041488 
VARIANT   1376   1376  1     F -> S (in dbSNP:rs17694720 [NCBI]). VAR_055987 
VARIANT   1416   1416  1     K -> N. VAR_041489 
VARIANT   1419   1419  1     E -> K. VAR_041490 
VARIANT   1429   1429  1     Q -> R. VAR_041491 
VARIANT   1461   1461  1     V -> I (in dbSNP:rs1670283 [NCBI]). VAR_031042 
VARIANT   1491   1491  1     K -> R (in dbSNP:rs1881420 [NCBI]). VAR_031043 
VARIANT   1529   1529  1     D -> E (in dbSNP:rs1881421 [NCBI]). VAR_031044 
VARIANT   1599   1599  1     P -> H (in dbSNP:rs1881423 [NCBI]). VAR_055988 
CONFLICT   36     36        P -> S (in Ref. 1; AAB71619). 
Sequence information
Length: 1620 AA [This is the length of the unprocessed precursor] Molecular weight: 176428 Da [This is the MW of the unprocessed precursor] CRC64: A4B96DFF6D329777 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MGAIGLLWLL PLLLSTAAVG SGMGTGQRAG SPAAGPPLQP REPLSYSRLQ RKSLAVDFVV 

        70         80         90        100        110        120 
PSLFRVYARD LLLPPSSSEL KAGRPEARGS LALDCAPLLR LLGPAPGVSW TAGSPAPAEA 

       130        140        150        160        170        180 
RTLSRVLKGG SVRKLRRAKQ LVLELGEEAI LEGCVGPPGE AAVGLLQFNL SELFSWWIRQ 

       190        200        210        220        230        240 
GEGRLRIRLM PEKKASEVGR EGRLSAAIRA SQPRLLFQIF GTGHSSLESP TNMPSPSPDY 

       250        260        270        280        290        300 
FTWNLTWIMK DSFPFLSHRS RYGLECSFDF PCELEYSPPL HDLRNQSWSW RRIPSEEASQ 

       310        320        330        340        350        360 
MDLLDGPGAE RSKEMPRGSF LLLNTSADSK HTILSPWMRS SSEHCTLAVS VHRHLQPSGR 

       370        380        390        400        410        420 
YIAQLLPHNE AAREILLMPT PGKHGWTVLQ GRIGRPDNPF RVALEYISSG NRSLSAVDFF 

       430        440        450        460        470        480 
ALKNCSEGTS PGSKMALQSS FTCWNGTVLQ LGQACDFHQD CAQGEDESQM CRKLPVGFYC 

       490        500        510        520        530        540 
NFEDGFCGWT QGTLSPHTPQ WQVRTLKDAR FQDHQDHALL LSTTDVPASE SATVTSATFP 

       550        560        570        580        590        600 
APIKSSPCEL RMSWLIRGVL RGNVSLVLVE NKTGKEQGRM VWHVAAYEGL SLWQWMVLPL 

       610        620        630        640        650        660 
LDVSDRFWLQ MVAWWGQGSR AIVAFDNISI SLDCYLTISG EDKILQNTAP KSRNLFERNP 

       670        680        690        700        710        720 
NKELKPGENS PRQTPIFDPT VHWLFTTCGA SGPHGPTQAQ CNNAYQNSNL SVEVGSEGPL 

       730        740        750        760        770        780 
KGIQIWKVPA TDTYSISGYG AAGGKGGKNT MMRSHGVSVL GIFNLEKDDM LYILVGQQGE 

       790        800        810        820        830        840 
DACPSTNQLI QKVCIGENNV IEEEIRVNRS VHEWAGGGGG GGGATYVFKM KDGVPVPLII 

       850        860        870        880        890        900 
AAGGGGRAYG AKTDTFHPER LENNSSVLGL NGNSGAAGGG GGWNDNTSLL WAGKSLQEGA 

       910        920        930        940        950        960 
TGGHSCPQAM KKWGWETRGG FGGGGGGCSS GGGGGGYIGG NAASNNDPEM DGEDGVSFIS 

       970        980        990       1000       1010       1020 
PLGILYTPAL KVMEGHGEVN IKHYLNCSHC EVDECHMDPE SHKVICFCDH GTVLAEDGVS 

      1030       1040       1050       1060       1070       1080 
CIVSPTPEPH LPLSLILSVV TSALVAALVL AFSGIMIVYR RKHQELQAMQ MELQSPEYKL 

      1090       1100       1110       1120       1130       1140 
SKLRTSTIMT DYNPNYCFAG KTSSISDLKE VPRKNITLIR GLGHGAFGEV YEGQVSGMPN 

      1150       1160       1170       1180       1190       1200 
DPSPLQVAVK TLPEVCSEQD ELDFLMEALI ISKFNHQNIV RCIGVSLQSL PRFILLELMA 

      1210       1220       1230       1240       1250       1260 
GGDLKSFLRE TRPRPSQPSS LAMLDLLHVA RDIACGCQYL EENHFIHRDI AARNCLLTCP 

      1270       1280       1290       1300       1310       1320 
GPGRVAKIGD FGMARDIYRA SYYRKGGCAM LPVKWMPPEA FMEGIFTSKT DTWSFGVLLW 

      1330       1340       1350       1360       1370       1380 
EIFSLGYMPY PSKSNQEVLE FVTSGGRMDP PKNCPGPVYR IMTQCWQHQP EDRPNFAIIL 

      1390       1400       1410       1420       1430       1440 
ERIEYCTQDP DVINTALPIE YGPLVEEEEK VPVRPKDPEG VPPLLVSQQA KREEERSPAA 

      1450       1460       1470       1480       1490       1500 
PPPLPTTSSG KAAKKPTAAE VSVRVPRGPA VEGGHVNMAF SQSNPPSELH KVHGSRNKPT 

      1510       1520       1530       1540       1550       1560 
SLWNPTYGSW FTEKPTKKNN PIAKKEPHDR GNLGLEGSCT VPPNVATGRL PGASLLLEPS 

      1570       1580       1590       1600       1610       1620 
SLTANMKEVP LFRLRHFPCG NVNYGYQQQG LPLEAATAPG AGHYEDTILK SKNSMNQPGP 

Q9UM73 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!